MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis
BackgroundRelatives of patients with familial interstitial pneumonia (FIP) are at increased risk for pulmonary fibrosis. We assessed the prevalence and risk factors for preclinical pulmonary fibrosis (PrePF) in first-degree relatives of patients with FIP and determined the utility of deep learning i...
Gespeichert in:
Veröffentlicht in: | Thorax 2019-12, Vol.74 (12), p.1131-1139 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1139 |
---|---|
container_issue | 12 |
container_start_page | 1131 |
container_title | Thorax |
container_volume | 74 |
creator | Mathai, Susan K Humphries, Stephen Kropski, Jonathan A Blackwell, Timothy S Powers, Julia Walts, Avram D Markin, Cheryl Woodward, Julia Chung, Jonathan H Brown, Kevin K Steele, Mark P Loyd, James E Schwarz, Marvin I Fingerlin, Tasha Yang, Ivana V Lynch, David A Schwartz, David A |
description | BackgroundRelatives of patients with familial interstitial pneumonia (FIP) are at increased risk for pulmonary fibrosis. We assessed the prevalence and risk factors for preclinical pulmonary fibrosis (PrePF) in first-degree relatives of patients with FIP and determined the utility of deep learning in detecting PrePF on CT.MethodsFirst-degree relatives of patients with FIP over 40 years of age who believed themselves to be unaffected by pulmonary fibrosis underwent CT scans of the chest. Images were visually reviewed, and a deep learning algorithm was used to quantify lung fibrosis. Genotyping for common idiopathic pulmonary fibrosis risk variants in MUC5B and TERT was performed.FindingsIn 494 relatives of patients with FIP from 263 families of patients with FIP, the prevalence of PrePF on visual CT evaluation was 15.6% (95% CI 12.6 to 19.0). Compared with visual CT evaluation, deep learning quantitative CT analysis had 84% sensitivity (95% CI 0.72 to 0.89) and 86% sensitivity (95% CI 0.83 to 0.89) for discriminating subjects with visual PrePF diagnosis. Subjects with PrePF were older (65.9, SD 10.1 years) than subjects without fibrosis (55.8 SD 8.7 years), more likely to be male (49% vs 37%), more likely to have smoked (44% vs 27%) and more likely to have the MUC5B promoter variant rs35705950 (minor allele frequency 0.29 vs 0.21). MUC5B variant carriers had higher quantitative CT fibrosis scores (mean difference of 0.36%), a difference that remains significant when controlling for age and sex.InterpretationPrePF is common in relatives of patients with FIP. Its prevalence increases with age and the presence of a common MUC5B promoter variant. Quantitative CT analysis can detect these imaging abnormalities. |
doi_str_mv | 10.1136/thoraxjnl-2018-212430 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7535073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3109448054</sourcerecordid><originalsourceid>FETCH-LOGICAL-b550t-7e49c732b033cb2f8d9ce7a5ab9f4a8e9e7336a97165e5cd647f746786343cd83</originalsourceid><addsrcrecordid>eNqNkcuKFDEYhYMoTtv6CEqBGzeluV82gjbeYMSNsw6pVMpOk0p6klTrvL1pemwvi8FVIPnO4f_zAfAUwZcIEf6qblM2P3Yx9Bgi2WOEKYH3wApRLnuCFb8PVhBS2HMi-AV4VMoOQigREg_BBUGMSY7xCoyfrzbsbXcw2ZtYO186U0qy3lQ3dt993XYHXxYTwk1n4thdL43y1VR_cO1qdNXZI7nPzgYfvTWh2y9hTtHkm27yQ07Fl8fgwWRCcU9uzzW4ev_u6-Zjf_nlw6fNm8t-YAzWXjiqrCB4gITYAU9yVNYJw8ygJmqkU04Qwo0SiDPH7MipmATlQnJCiR0lWYPXp979MsxutC7WbILeZz-3cXQyXv_9Ev1Wf0sHLRhhsJWvwYvbgpyuF1eqnn2xLgQTXVqKxlgpRKigsKHP_0F3acmxracJgopSCRm9i8IENQg3JY1iJ8q27yrZTeeREdRH2_psWx9t65Ptlnv2577n1C-9DYAnYJh3_92JfkfOw96d-Ql158lv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314482081</pqid></control><display><type>article</type><title>MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Mathai, Susan K ; Humphries, Stephen ; Kropski, Jonathan A ; Blackwell, Timothy S ; Powers, Julia ; Walts, Avram D ; Markin, Cheryl ; Woodward, Julia ; Chung, Jonathan H ; Brown, Kevin K ; Steele, Mark P ; Loyd, James E ; Schwarz, Marvin I ; Fingerlin, Tasha ; Yang, Ivana V ; Lynch, David A ; Schwartz, David A</creator><creatorcontrib>Mathai, Susan K ; Humphries, Stephen ; Kropski, Jonathan A ; Blackwell, Timothy S ; Powers, Julia ; Walts, Avram D ; Markin, Cheryl ; Woodward, Julia ; Chung, Jonathan H ; Brown, Kevin K ; Steele, Mark P ; Loyd, James E ; Schwarz, Marvin I ; Fingerlin, Tasha ; Yang, Ivana V ; Lynch, David A ; Schwartz, David A</creatorcontrib><description>BackgroundRelatives of patients with familial interstitial pneumonia (FIP) are at increased risk for pulmonary fibrosis. We assessed the prevalence and risk factors for preclinical pulmonary fibrosis (PrePF) in first-degree relatives of patients with FIP and determined the utility of deep learning in detecting PrePF on CT.MethodsFirst-degree relatives of patients with FIP over 40 years of age who believed themselves to be unaffected by pulmonary fibrosis underwent CT scans of the chest. Images were visually reviewed, and a deep learning algorithm was used to quantify lung fibrosis. Genotyping for common idiopathic pulmonary fibrosis risk variants in MUC5B and TERT was performed.FindingsIn 494 relatives of patients with FIP from 263 families of patients with FIP, the prevalence of PrePF on visual CT evaluation was 15.6% (95% CI 12.6 to 19.0). Compared with visual CT evaluation, deep learning quantitative CT analysis had 84% sensitivity (95% CI 0.72 to 0.89) and 86% sensitivity (95% CI 0.83 to 0.89) for discriminating subjects with visual PrePF diagnosis. Subjects with PrePF were older (65.9, SD 10.1 years) than subjects without fibrosis (55.8 SD 8.7 years), more likely to be male (49% vs 37%), more likely to have smoked (44% vs 27%) and more likely to have the MUC5B promoter variant rs35705950 (minor allele frequency 0.29 vs 0.21). MUC5B variant carriers had higher quantitative CT fibrosis scores (mean difference of 0.36%), a difference that remains significant when controlling for age and sex.InterpretationPrePF is common in relatives of patients with FIP. Its prevalence increases with age and the presence of a common MUC5B promoter variant. Quantitative CT analysis can detect these imaging abnormalities.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2018-212430</identifier><identifier>PMID: 31558622</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>Aged ; Algorithms ; Classification ; Colorado - epidemiology ; Deep Learning ; Female ; Genetic Predisposition to Disease ; Genetic Variation ; Health risks ; Heredity ; Humans ; Idiopathic Interstitial Pneumonias - diagnostic imaging ; Idiopathic Interstitial Pneumonias - epidemiology ; Idiopathic Interstitial Pneumonias - genetics ; Idiopathic pulmonary fibrosis ; Idiopathic Pulmonary Fibrosis - diagnostic imaging ; Idiopathic Pulmonary Fibrosis - epidemiology ; Idiopathic Pulmonary Fibrosis - genetics ; Imaging/CT MRI etc ; Interstitial Fibrosis ; Interstitial lung disease ; Lung cancer ; Lung diseases ; Male ; Medical imaging ; Medical screening ; Middle Aged ; Mortality ; Mucin-5B - genetics ; Physiology ; Pneumonia ; Polymorphism ; Population ; Prevalence ; Promoter Regions, Genetic - genetics ; Pulmonary fibrosis ; Risk Factors ; ROC Curve ; Teaching methods ; Telomerase - genetics ; Tomography, X-Ray Computed</subject><ispartof>Thorax, 2019-12, Vol.74 (12), p.1131-1139</ispartof><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b550t-7e49c732b033cb2f8d9ce7a5ab9f4a8e9e7336a97165e5cd647f746786343cd83</citedby><cites>FETCH-LOGICAL-b550t-7e49c732b033cb2f8d9ce7a5ab9f4a8e9e7336a97165e5cd647f746786343cd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31558622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mathai, Susan K</creatorcontrib><creatorcontrib>Humphries, Stephen</creatorcontrib><creatorcontrib>Kropski, Jonathan A</creatorcontrib><creatorcontrib>Blackwell, Timothy S</creatorcontrib><creatorcontrib>Powers, Julia</creatorcontrib><creatorcontrib>Walts, Avram D</creatorcontrib><creatorcontrib>Markin, Cheryl</creatorcontrib><creatorcontrib>Woodward, Julia</creatorcontrib><creatorcontrib>Chung, Jonathan H</creatorcontrib><creatorcontrib>Brown, Kevin K</creatorcontrib><creatorcontrib>Steele, Mark P</creatorcontrib><creatorcontrib>Loyd, James E</creatorcontrib><creatorcontrib>Schwarz, Marvin I</creatorcontrib><creatorcontrib>Fingerlin, Tasha</creatorcontrib><creatorcontrib>Yang, Ivana V</creatorcontrib><creatorcontrib>Lynch, David A</creatorcontrib><creatorcontrib>Schwartz, David A</creatorcontrib><title>MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis</title><title>Thorax</title><addtitle>Thorax</addtitle><addtitle>Thorax</addtitle><description>BackgroundRelatives of patients with familial interstitial pneumonia (FIP) are at increased risk for pulmonary fibrosis. We assessed the prevalence and risk factors for preclinical pulmonary fibrosis (PrePF) in first-degree relatives of patients with FIP and determined the utility of deep learning in detecting PrePF on CT.MethodsFirst-degree relatives of patients with FIP over 40 years of age who believed themselves to be unaffected by pulmonary fibrosis underwent CT scans of the chest. Images were visually reviewed, and a deep learning algorithm was used to quantify lung fibrosis. Genotyping for common idiopathic pulmonary fibrosis risk variants in MUC5B and TERT was performed.FindingsIn 494 relatives of patients with FIP from 263 families of patients with FIP, the prevalence of PrePF on visual CT evaluation was 15.6% (95% CI 12.6 to 19.0). Compared with visual CT evaluation, deep learning quantitative CT analysis had 84% sensitivity (95% CI 0.72 to 0.89) and 86% sensitivity (95% CI 0.83 to 0.89) for discriminating subjects with visual PrePF diagnosis. Subjects with PrePF were older (65.9, SD 10.1 years) than subjects without fibrosis (55.8 SD 8.7 years), more likely to be male (49% vs 37%), more likely to have smoked (44% vs 27%) and more likely to have the MUC5B promoter variant rs35705950 (minor allele frequency 0.29 vs 0.21). MUC5B variant carriers had higher quantitative CT fibrosis scores (mean difference of 0.36%), a difference that remains significant when controlling for age and sex.InterpretationPrePF is common in relatives of patients with FIP. Its prevalence increases with age and the presence of a common MUC5B promoter variant. Quantitative CT analysis can detect these imaging abnormalities.</description><subject>Aged</subject><subject>Algorithms</subject><subject>Classification</subject><subject>Colorado - epidemiology</subject><subject>Deep Learning</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Variation</subject><subject>Health risks</subject><subject>Heredity</subject><subject>Humans</subject><subject>Idiopathic Interstitial Pneumonias - diagnostic imaging</subject><subject>Idiopathic Interstitial Pneumonias - epidemiology</subject><subject>Idiopathic Interstitial Pneumonias - genetics</subject><subject>Idiopathic pulmonary fibrosis</subject><subject>Idiopathic Pulmonary Fibrosis - diagnostic imaging</subject><subject>Idiopathic Pulmonary Fibrosis - epidemiology</subject><subject>Idiopathic Pulmonary Fibrosis - genetics</subject><subject>Imaging/CT MRI etc</subject><subject>Interstitial Fibrosis</subject><subject>Interstitial lung disease</subject><subject>Lung cancer</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mucin-5B - genetics</subject><subject>Physiology</subject><subject>Pneumonia</subject><subject>Polymorphism</subject><subject>Population</subject><subject>Prevalence</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Pulmonary fibrosis</subject><subject>Risk Factors</subject><subject>ROC Curve</subject><subject>Teaching methods</subject><subject>Telomerase - genetics</subject><subject>Tomography, X-Ray Computed</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkcuKFDEYhYMoTtv6CEqBGzeluV82gjbeYMSNsw6pVMpOk0p6klTrvL1pemwvi8FVIPnO4f_zAfAUwZcIEf6qblM2P3Yx9Bgi2WOEKYH3wApRLnuCFb8PVhBS2HMi-AV4VMoOQigREg_BBUGMSY7xCoyfrzbsbXcw2ZtYO186U0qy3lQ3dt993XYHXxYTwk1n4thdL43y1VR_cO1qdNXZI7nPzgYfvTWh2y9hTtHkm27yQ07Fl8fgwWRCcU9uzzW4ev_u6-Zjf_nlw6fNm8t-YAzWXjiqrCB4gITYAU9yVNYJw8ygJmqkU04Qwo0SiDPH7MipmATlQnJCiR0lWYPXp979MsxutC7WbILeZz-3cXQyXv_9Ev1Wf0sHLRhhsJWvwYvbgpyuF1eqnn2xLgQTXVqKxlgpRKigsKHP_0F3acmxracJgopSCRm9i8IENQg3JY1iJ8q27yrZTeeREdRH2_psWx9t65Ptlnv2577n1C-9DYAnYJh3_92JfkfOw96d-Ql158lv</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Mathai, Susan K</creator><creator>Humphries, Stephen</creator><creator>Kropski, Jonathan A</creator><creator>Blackwell, Timothy S</creator><creator>Powers, Julia</creator><creator>Walts, Avram D</creator><creator>Markin, Cheryl</creator><creator>Woodward, Julia</creator><creator>Chung, Jonathan H</creator><creator>Brown, Kevin K</creator><creator>Steele, Mark P</creator><creator>Loyd, James E</creator><creator>Schwarz, Marvin I</creator><creator>Fingerlin, Tasha</creator><creator>Yang, Ivana V</creator><creator>Lynch, David A</creator><creator>Schwartz, David A</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20191201</creationdate><title>MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis</title><author>Mathai, Susan K ; Humphries, Stephen ; Kropski, Jonathan A ; Blackwell, Timothy S ; Powers, Julia ; Walts, Avram D ; Markin, Cheryl ; Woodward, Julia ; Chung, Jonathan H ; Brown, Kevin K ; Steele, Mark P ; Loyd, James E ; Schwarz, Marvin I ; Fingerlin, Tasha ; Yang, Ivana V ; Lynch, David A ; Schwartz, David A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b550t-7e49c732b033cb2f8d9ce7a5ab9f4a8e9e7336a97165e5cd647f746786343cd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Algorithms</topic><topic>Classification</topic><topic>Colorado - epidemiology</topic><topic>Deep Learning</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Variation</topic><topic>Health risks</topic><topic>Heredity</topic><topic>Humans</topic><topic>Idiopathic Interstitial Pneumonias - diagnostic imaging</topic><topic>Idiopathic Interstitial Pneumonias - epidemiology</topic><topic>Idiopathic Interstitial Pneumonias - genetics</topic><topic>Idiopathic pulmonary fibrosis</topic><topic>Idiopathic Pulmonary Fibrosis - diagnostic imaging</topic><topic>Idiopathic Pulmonary Fibrosis - epidemiology</topic><topic>Idiopathic Pulmonary Fibrosis - genetics</topic><topic>Imaging/CT MRI etc</topic><topic>Interstitial Fibrosis</topic><topic>Interstitial lung disease</topic><topic>Lung cancer</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mucin-5B - genetics</topic><topic>Physiology</topic><topic>Pneumonia</topic><topic>Polymorphism</topic><topic>Population</topic><topic>Prevalence</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Pulmonary fibrosis</topic><topic>Risk Factors</topic><topic>ROC Curve</topic><topic>Teaching methods</topic><topic>Telomerase - genetics</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mathai, Susan K</creatorcontrib><creatorcontrib>Humphries, Stephen</creatorcontrib><creatorcontrib>Kropski, Jonathan A</creatorcontrib><creatorcontrib>Blackwell, Timothy S</creatorcontrib><creatorcontrib>Powers, Julia</creatorcontrib><creatorcontrib>Walts, Avram D</creatorcontrib><creatorcontrib>Markin, Cheryl</creatorcontrib><creatorcontrib>Woodward, Julia</creatorcontrib><creatorcontrib>Chung, Jonathan H</creatorcontrib><creatorcontrib>Brown, Kevin K</creatorcontrib><creatorcontrib>Steele, Mark P</creatorcontrib><creatorcontrib>Loyd, James E</creatorcontrib><creatorcontrib>Schwarz, Marvin I</creatorcontrib><creatorcontrib>Fingerlin, Tasha</creatorcontrib><creatorcontrib>Yang, Ivana V</creatorcontrib><creatorcontrib>Lynch, David A</creatorcontrib><creatorcontrib>Schwartz, David A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mathai, Susan K</au><au>Humphries, Stephen</au><au>Kropski, Jonathan A</au><au>Blackwell, Timothy S</au><au>Powers, Julia</au><au>Walts, Avram D</au><au>Markin, Cheryl</au><au>Woodward, Julia</au><au>Chung, Jonathan H</au><au>Brown, Kevin K</au><au>Steele, Mark P</au><au>Loyd, James E</au><au>Schwarz, Marvin I</au><au>Fingerlin, Tasha</au><au>Yang, Ivana V</au><au>Lynch, David A</au><au>Schwartz, David A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis</atitle><jtitle>Thorax</jtitle><stitle>Thorax</stitle><addtitle>Thorax</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>74</volume><issue>12</issue><spage>1131</spage><epage>1139</epage><pages>1131-1139</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>BackgroundRelatives of patients with familial interstitial pneumonia (FIP) are at increased risk for pulmonary fibrosis. We assessed the prevalence and risk factors for preclinical pulmonary fibrosis (PrePF) in first-degree relatives of patients with FIP and determined the utility of deep learning in detecting PrePF on CT.MethodsFirst-degree relatives of patients with FIP over 40 years of age who believed themselves to be unaffected by pulmonary fibrosis underwent CT scans of the chest. Images were visually reviewed, and a deep learning algorithm was used to quantify lung fibrosis. Genotyping for common idiopathic pulmonary fibrosis risk variants in MUC5B and TERT was performed.FindingsIn 494 relatives of patients with FIP from 263 families of patients with FIP, the prevalence of PrePF on visual CT evaluation was 15.6% (95% CI 12.6 to 19.0). Compared with visual CT evaluation, deep learning quantitative CT analysis had 84% sensitivity (95% CI 0.72 to 0.89) and 86% sensitivity (95% CI 0.83 to 0.89) for discriminating subjects with visual PrePF diagnosis. Subjects with PrePF were older (65.9, SD 10.1 years) than subjects without fibrosis (55.8 SD 8.7 years), more likely to be male (49% vs 37%), more likely to have smoked (44% vs 27%) and more likely to have the MUC5B promoter variant rs35705950 (minor allele frequency 0.29 vs 0.21). MUC5B variant carriers had higher quantitative CT fibrosis scores (mean difference of 0.36%), a difference that remains significant when controlling for age and sex.InterpretationPrePF is common in relatives of patients with FIP. Its prevalence increases with age and the presence of a common MUC5B promoter variant. Quantitative CT analysis can detect these imaging abnormalities.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>31558622</pmid><doi>10.1136/thoraxjnl-2018-212430</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 2019-12, Vol.74 (12), p.1131-1139 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7535073 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Algorithms Classification Colorado - epidemiology Deep Learning Female Genetic Predisposition to Disease Genetic Variation Health risks Heredity Humans Idiopathic Interstitial Pneumonias - diagnostic imaging Idiopathic Interstitial Pneumonias - epidemiology Idiopathic Interstitial Pneumonias - genetics Idiopathic pulmonary fibrosis Idiopathic Pulmonary Fibrosis - diagnostic imaging Idiopathic Pulmonary Fibrosis - epidemiology Idiopathic Pulmonary Fibrosis - genetics Imaging/CT MRI etc Interstitial Fibrosis Interstitial lung disease Lung cancer Lung diseases Male Medical imaging Medical screening Middle Aged Mortality Mucin-5B - genetics Physiology Pneumonia Polymorphism Population Prevalence Promoter Regions, Genetic - genetics Pulmonary fibrosis Risk Factors ROC Curve Teaching methods Telomerase - genetics Tomography, X-Ray Computed |
title | MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A37%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MUC5B%20variant%20is%20associated%20with%20visually%20and%20quantitatively%20detected%20preclinical%20pulmonary%20fibrosis&rft.jtitle=Thorax&rft.au=Mathai,%20Susan%20K&rft.date=2019-12-01&rft.volume=74&rft.issue=12&rft.spage=1131&rft.epage=1139&rft.pages=1131-1139&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thoraxjnl-2018-212430&rft_dat=%3Cproquest_pubme%3E3109448054%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2314482081&rft_id=info:pmid/31558622&rfr_iscdi=true |